Immunological mechanisms of mRNA vaccines for infectious diseases

Hogan, M. J. & Pardi, N. mRNA vaccines in the COVID-19 pandemic and beyond. Annu. Rev. Med. 73, 17–39 (2022).

Article

CAS

PubMed

Google Scholar

Zhang, G., Tang, T., Chen, Y., Huang, X. & Liang, T. mRNA vaccines in disease prevention and treatment. Signal Transduct. Target. Ther. 8, 365 (2023).

Article

CAS

PubMed

PubMed Central

Google Scholar

Sahin, U., Kariko, K. & Tureci, O. mRNA-based therapeutics—developing a new class of drugs. Nat. Rev. Drug Discov. 13, 759–780 (2014).

Article

CAS

PubMed

Google Scholar

Chaudhary, N., Weissman, D. & Whitehead, K. A. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat. Rev. Drug Discov. 20, 817–838 (2021).

Article

CAS

PubMed

PubMed Central

Google Scholar

Pardi, N. & Krammer, F. mRNA vaccines for infectious diseases—advances, challenges and opportunities. Nat. Rev. Drug Discov. 23, 838–861 (2024).

Article

CAS

PubMed

PubMed Central

Google Scholar

Srivastava, K. et al. SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase. Immunity 57, 587–599 (2024).

Article

CAS

PubMed

PubMed Central

Google Scholar

Zhang, Z. L. et al. Humoral and cellular immune memory to four COVID-19 vaccines. Cell 185, 2434–2451 (2022).

Article

CAS

PubMed

PubMed Central

Google Scholar

Arunachalam, P. S. et al. Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature 596, 410–416 (2021).

Article

ADS

CAS

PubMed

PubMed Central

Google Scholar

Ryan, F. J. et al. A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines. Cell Rep. Med. 4, 100971 (2023).

Article

CAS

PubMed

PubMed Central

Google Scholar

Saresella, M. et al. Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine. Front. Immunol. 13, 947320 (2022).

Article

CAS

PubMed

PubMed Central

Google Scholar

Schramm, C. A. et al. Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primates. Nat. Commun. 14, 7961 (2023).

Article

ADS

CAS

PubMed

PubMed Central

Google Scholar

Jakubzick, C. V., Randolph, G. J. & Henson, P. M. Monocyte differentiation and antigen-presenting functions. Nat. Rev. Immunol. 17, 349–362 (2017).

Article

CAS

PubMed

Google Scholar

Hellgren, F. et al. Modulation of innate immune response to mRNA vaccination after SARS-CoV-2 infection or sequential vaccination in humans. JCI Insight 9, e175401 (2024).

Article

PubMed

PubMed Central

Google Scholar

Netea, M. G. et al. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. 20, 375–388 (2020).

Article

CAS

PubMed

PubMed Central

Google Scholar

Stevens, N. E. et al. No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines. J. Clin. Invest. 133, e171742 (2023).

Article

CAS

PubMed

PubMed Central

Google Scholar

Yamaguchi, Y. et al. Consecutive BNT162b2 mRNA vaccination induces short-term epigenetic memory in innate immune cells. JCI Insight 7, e163347 (2022).

Article

PubMed

PubMed Central

Google Scholar

Liang, F. et al. Efficient targeting and activation of antigen-presenting cells in vivo after modified mRNA vaccine administration in Rhesus macaques. Mol. Ther. 25, 2635–2647 (2017).This is the first study providing a detailed characterization of the innate cells that efficiently internalize mRNA–LNP and express the mRNA in vivo in NHPs.

Article

CAS

PubMed

PubMed Central

Google Scholar

Li, C. et al. Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine. Nat. Immunol. 23, 543–555 (2022).This seminal study shows the importance of type I IFNs in inducing CD8+ T cell responses to the BNT162b2 vaccine, and evaluates the importance of many PRRs in the sensing of the BNT162b2 vaccine.

Article

CAS

PubMed

PubMed Central

Google Scholar

Hassett, K. J. et al. mRNA vaccine trafficking and resulting protein expression after intramuscular administration. Mol. Ther. Nucleic Acids 35, 102083 (2024).

Article

CAS

PubMed

Google Scholar

Castano, D. et al. Distinct components of mRNA vaccines cooperate to instruct efficient germinal center responses. Cell 188, 7461–7480 (2025).This study demonstrates that the nucleoside-modified mRNA component is not immunosilent, and contributes to shaping TFH and B cell responses to the vaccine through a mechanism requiring IRF3–IRF7-driven type I IFNs.

Article

CAS

PubMed

PubMed Central

Google Scholar

Kim, S. et al. Innate immune responses against mRNA vaccine promote cellular immunity through IFN-β at the injection site. Nat. Commun. 15, 7226 (2024).

Article

ADS

CAS

PubMed

PubMed Central

Google Scholar

Krishnaswamy, J. K. et al. Migratory CD11b+ conventional dendritic cells induce T follicular helper cell-dependent antibody responses. Sci. Immunol. 2, eaam9169 (2017).

Article

PubMed

PubMed Central

Google Scholar

Gerner, M. Y., Casey, K. A., Kastenmuller, W. & Germain, R. N. Dendritic cell and antigen dispersal landscapes regulate T cell immunity. J. Exp. Med. 214, 3105–3122 (2017).

Article

CAS

PubMed

PubMed Central

Google Scholar

Gerner, M. Y., Torabi-Parizi, P. & Germain, R. N. Strategically localized dendritic cells promote rapid T cell responses to lymph-borne particulate antigens. Immunity 42, 172–185 (2015).

Article

CAS

PubMed

Google Scholar

Buckley, M. et al. Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates. Mol. Ther. 33, 1105–1117 (2025).

Article

CAS

PubMed

PubMed Central

Google Scholar

Reizis, B. Plasmacytoid dendritic cells: development, regulation, and function. Immunity 50, 37–50 (2019).

Article

CAS

PubMed

Google Scholar

Arroyo Hornero, R. & Idoyaga, J. Plasmacytoid dendritic cells: a dendritic cell in disguise. Mol. Immunol. 159, 38–45 (2023).

Article

CAS

PubMed

PubMed Central

Google Scholar

Dudziak, D. et al. Differential antigen processing by dendritic cell subsets in vivo. Science 315, 107–111 (2007).

Article

ADS

CAS

PubMed

Google Scholar

Lehmann, C. H. K. et al. DC subset-specific induction of T cell responses upon antigen uptake via Fcγ receptors in vivo. J. Exp. Med. 214, 1509–1528 (2017).

Article

CAS

PubMed

PubMed Central

Google Scholar

Miller, M. A., Ganesan, A. P., Luckashenak, N., Mendonca, M. & Eisenlohr, L. C. Endogenous antigen processing drives the primary CD4+ T cell response to influenza. Nat. Med. 21, 1216–1222 (2015).

Article

CAS

PubMed

PubMed Central

Google Scholar

Pardi, N. et al. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes. J. Control. Release 217, 345–351 (2015).

Article

CAS

PubMed

PubMed Central

Google Scholar

Tanji, H. et al. Toll-like receptor 8 senses degradation products of single-stranded RNA. Nat. Struct. Mol. Biol. 22, 109–115 (2015).

Article

CAS

PubMed

Google Scholar

Zhang, Z. et al. Structural analysis reveals that Toll-like receptor 7 is a dual receptor for guanosine and single-stranded RNA. Immunity 45, 737–748 (2016).

Article

CAS

PubMed

Google Scholar

Brubaker, S. W., Bonham, K. S., Zanoni, I. & Kagan, J. C. Innate immune pattern recognition: a cell biological perspective. Annu. Rev. Immunol. 33, 257–290 (2015).

Article

CAS

PubMed

PubMed Central

Google Scholar

Anderson, B. R. et al. Nucleoside modifications in RNA limit activation of 2′-5′-oligoadenylate synthetase and increase resistance to cleavage by RNase L. Nucleic Acids Res. 39, 9329–9338 (2011).

Article

CAS

PubMed

PubMed Central

Google Scholar

Anderson, B. R. et al. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res. 38, 5884–5892 (2010).

Article

CAS

PubMed

PubMed Central

Google Scholar

Karikó, K., Buckstein, M., Ni, H. & Weissman, D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165–175 (2005).Elegant study showing that nucleoside modification in RNA can decrease its innate immune sensing.

Article

CAS

PubMed

Google Scholar

Karikó, K. et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16, 1833–1840 (2008).

Article

CAS

PubMed

PubMed Central

Google Scholar

Karikó, K., Muramatsu, H., Ludwig, J. & Weissman, D. Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA. Nucleic Acids Res. 39, e142 (2011).

Article

CAS

PubMed

PubMed Central

Google Scholar

Mauger, D. M. et al. mRNA structure regulates protein expression through changes in functional half-life. Proc. Natl Acad. Sci. USA 116, 24075–24083 (2019).

Article

ADS

CAS

PubMed

PubMed Central

Google Scholar

Zhang, H. et al. Algorithm for optimized mRNA design improves stability and immunogenicity. Nature 621, 396–403 (2023).

Article

ADS

CAS

PubMed

PubMed Central

Google Scholar

Abbas, Y. M. et al. Structure of human IFIT1 with capped RNA reveals adaptable mRNA binding and mechanisms for sensing N1 and N2 ribose 2′-O methylations. Proc. Natl Acad. Sci. USA 114, E2106–E2115 (2017).

Article

CAS

PubMed

PubMed Central

Google Scholar

Connors, J. et al. Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals. Commun. Biol. 6, 188 (2023).

Article

CAS

PubMed

PubMed Central

Google Scholar

Bastard, P. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370, eabd4585 (2020).

Article

CAS

PubMed

PubMed Central

Google Scholar

Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036–1045.e1039 (2020).

Article

ADS

CAS

PubMed

PubMed Central

Google Scholar

Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370, eabd4570 (2020).

Article

CAS

PubMed

PubMed Central

Google Scholar

Sen, G., Khan, A. Q., Chen, Q. & Snapper, C. M. In vivo humoral immune responses to isolated pneumococcal polysaccharides are dependent on the presence of associated TLR ligands. J. Immunol. 175, 3084–3091 (2005).

Article

CAS

PubMed

Google Scholar

Alameh, M. G. et al. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses. Immunity 54, 2877–2892 (2021).This study shows that the LNP component of mRNA vaccines possesses inherent adjuvant activity and that LNP mechanistically drives TFH cell differentiation through induction of IL-6.

Article

CAS

PubMed

PubMed Central

Google Scholar

Kierzek, E. et al. The contribution of pseudouridine to stabilities and structure of RNAs. Nucleic Acids Res. 42, 3492–3501 (2014).

Article

CAS

PubMed

Google Scholar

Kaiser, S., Kaiser, S., Reis, J. & Marschalek, R. Quantification of objective concentrations of DNA impurities in mRNA vaccines. Vaccine 55, 127022 (2025).

Article

CAS

PubMed

Google Scholar

Akinc, A. et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nat. Nanotechnol. 14, 1084–1087 (2019).

Article

ADS

CAS

PubMed

Google Scholar

Geall, A. J. et al. Nonviral delivery of self-amplifying RNA vaccines. Proc. Natl Acad. Sci. USA 109, 14604–14609 (2012). The first published study that used LNPs for RNA vaccine delivery.

Article

ADS

CAS

PubMed

PubMed Central

Google Scholar

Cullis, P. R. & Felgner, P. L. The 60-year evolution of lipid nanoparticles for nucleic acid delivery. Nat. Rev. Drug Discov. 23, 709–722 (2024).

Article

CAS

PubMed

Google Scholar

Tahtinen, S. et al. IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines. Nat. Immunol. 23, 532–542 (2022). This seminal study highlights the role of IL-1 in vaccine reactogenicity, and demonstrates that mice are not ideal animal models for studying vaccine reactogenicity owing to high expression of IL-1RA in mice but not in humans.

Article

CAS

PubMed

Google Scholar

Lonez, C. et al. Cationic lipid nanocarriers activate Toll-like receptor 2 and NLRP3 inflammasome pathways. Nanomedicine 10, 775–782 (2014).

Article

CAS

PubMed

Google Scholar

Miao, L. et al. Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation. Nat. Biotechnol. 37, 1174–1185 (2019).

Article

CAS

PubMed

Google Scholar

Tanaka, T. et al. DiC14-amidine cationic liposomes stimulate myeloid dendritic cells through Toll-like receptor 4. Eur. J. Immunol. 38, 1351–1357 (2008).

Article

CAS

PubMed

Google Scholar

Fitzgerald, K. A. & Kagan, J. C. Toll-like receptors and the control of immunity. Cell 180, 1044–1066 (2020).

Article

ADS

CAS

PubMed

PubMed Central

Google Scholar

Chen, S. P. & Blakney, A. K. Immune response to the components of lipid nanoparticles for ribonucleic acid therapeutics. Curr. Opin. Biotech. 85, 103049 (2024).

Article

CAS

PubMed

Google Scholar

Zhivaki, D. & Kagan, J. C. Innate immune detection of lipid oxidation as a threat assessment strategy. Nat. Rev. Immunol. 22, 322–330 (2022).

Article

CAS

PubMed

Google Scholar

Packer, M., Gyawali, D., Yerabolu, R., Schariter, J. & White, P. A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems. Nat. Commun. 12, 6777 (2021).

Article

ADS

CAS

PubMed

PubMed Central

Google Scholar

Chaudhary, N. et al. Amine headgroups in ionizable lipids drive immune responses to lipid nanoparticles by binding to the receptors TLR4 and CD1d. Nat. Biomed. Eng. 8, 1483–1498 (2024).

Article

CAS

PubMed

PubMed Central

Google Scholar

Liu, F. T. & Stowell, S. R. The role of galectins in immunity and infection. Nat. Rev. Immunol. 23, 479–494 (2023).

Article

CAS

PubMed

PubMed Central

Google Scholar

Omo-Lamai, S. et al. Limiting endosomal damage sensing reduces inflammation triggered by lipid nanoparticle endosomal escape. Nat. Nanotechnol. 20, 1285–1297 (2025).

Article

ADS

CAS

PubMed

PubMed Central

Google Scholar

Semple, S. C., Chonn, A. & Cullis, P. R. Influence of cholesterol on the association of plasma proteins with liposomes. Biochemistry 35, 2521–2525 (1996).

Article

CAS

PubMed

Google Scholar

King, R. J., Singh, P. K. & Mehla, K. The cholesterol pathway: impact on immunity and cancer. Trends Immunol. 43, 78–92 (2022).

Article

CAS

PubMed

PubMed Central

Google Scholar

Cyster, J. G., Dang, E. V., Reboldi, A. & Yi, T. S. 25-Hydroxycholesterols in innate and adaptive immunity. Nat. Rev. Immunol. 14, 731–743 (2014).

Article

CAS

PubMed

Google Scholar

Medjmedj, A. et al. In cellulo and in vivo comparison of cholesterol, beta-sitosterol and dioleylphosphatidylethanolamine for lipid nanoparticle formulation of mRNA. Nanomaterials 12, 2446 (2022).

Article

CAS

PubMed

PubMed Central

Google Scholar

Patel, S. et al. Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA. Nat. Commun. 11, 3435 (2020).

Article

ADS

PubMed

PubMed Central

Google Scholar

Zeng, Y., Escalona-Rayo, O., Knol, R., Kros, A. & Slütter, B. Lipid nanoparticle-based mRNA candidates elicit potent T cell responses. Biomater. Sci. 11, 964–974 (2023).

Article

CAS

PubMed

Google Scholar

Sette, A. & Crotty, S. Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines. Immunol. Rev. 310, 27–46 (2022).

Article

CAS

PubMed

PubMed Central

Google Scholar

Lederer, K. et al. Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals. Cell 185, 1008–1024 (2022).

Article

CAS

PubMed

PubMed Central

Google Scholar

Lederer, K. et al. SARS-CoV-2 mRNA vaccines foster potent antigen-specific germinal center responses associated with neutralizing antibody generation. Immunity 53, 1281–1295 (2020).

Article

CAS

PubMed

PubMed Central

Google Scholar

Turner, J. S. et al. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature 596, 109–113 (2021).

Article

ADS

CAS

PubMed

PubMed Central

Google Scholar

Vogel, A. B. et al. BNT162b vaccines protect rhesus macaques from SARS-CoV-2. Nature 592, 283–289 (2021).

Article

ADS

CAS

PubMed

Google Scholar

Laczko, D. et al. A single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice. Immunity 53, 724–732 (2020).

Article

CAS

PubMed

PubMed Central

Google Scholar

Röltgen, K. et al. Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination. Cell 185, 1025–1040 (2022).

Article

CAS

PubMed

PubMed Central

Google Scholar

Kim, W. et al. Germinal centre-driven maturation of B cell response to mRNA vaccination. Nature 604, 141–145 (2022).

Article

ADS

CAS

PubMed

PubMed Central

Google Scholar

Cho, A. et al. Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination. Nature 600, 517–522 (2021).

Article

ADS

CAS

PubMed

PubMed Central

Google Scholar

Goel, R. R. et al. mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. Science 374, eabm0829 (2021).

Article

CAS

Google Scholar

Goldblatt, D., Alter, G., Crotty, S. & Plotkin, S. A. Correlates of protection against SARS-CoV-2 infection and COVID-19 disease. Immunol. Rev. 310, 6–26 (2022).

Article

CAS

PubMed

PubMed Central

Google Scholar

Corbett, K. S. et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature 586, 567–571 (2020).

Article

ADS

CAS

PubMed

PubMed Central

Google Scholar

Guerrera, G. et al. BNT162b2 vaccination induces durable SARS-CoV-2-specific T cells with a stem cell memory phenotype. Sci. Immunol. 6, eabl5344 (2021).

Article

CAS

PubMed

Google Scholar

Mateus, J. et al. Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells. Science 374, eabj9853 (2021).

Article

CAS

PubMed

Google Scholar

Aunins, E. A. et al. An Il12 mRNA-LNP adjuvant enhances mRNA vaccine-induced CD8 T cell responses. Sci. Immunol. 10, eads1328 (2025).

Article

CAS

PubMed

PubMed Central

Google Scholar

Iwasaki, A. & Medzhitov, R. Control of adaptive immunity by the innate immune system. Nat. Immunol. 16, 343–353 (2015).

Article

CAS

PubMed

PubMed Central

Google Scholar

Eto, D. et al. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS ONE 6, e17739 (2011).

Article

ADS

CAS

PubMed

PubMed Central

Google Scholar

Schmitt, N. et al. The cytokine TGF-β co-opts signaling via STAT3-STAT4 to promote the differentiation of human TFH cells. Nat. Immunol. 15, 856–865 (2014).

Article

PubMed

PubMed Central

Google Scholar

Schmitt, N. et al. Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. Immunity 31, 158–169 (2009).

Article

CAS

PubMed

PubMed Central

Google Scholar

Bergamaschi, C. et al. Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients. Cell Rep. 36, 109504 (2021).

Article

CAS

PubMed

PubMed Central

Google Scholar

Sokal, A. et al. Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination. J. Exp. Med. 220, e20220258 (2022).

Article

PubMed

PubMed Central

Google Scholar

Lu, E., Dang, E. V., McDonald, J. G. & Cyster, J. G. Distinct oxysterol requirements for positioning naive and activated dendritic cells in the spleen. Sci. Immunol. 2, eaal5237 (2017).

Article

PubMed

PubMed Central

Google Scholar

Li, J., Lu, E., Yi, T. & Cyster, J. G. EBI2 augments Tfh cell fate by promoting interaction with IL-2-quenching dendritic cells. Nature 533, 110–114 (2016).

Article

ADS

CAS

PubMed

PubMed Central

Google Scholar

Dilliard, S. A. & Siegwart, D. J. Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. Nat. Rev. Mater. 8, 282–300 (2023).

Article

CAS

PubMed

PubMed Central

Google Scholar

Bachmann, M. F. & Jennings, G. T. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat. Rev. Immunol. 10, 787–796 (2010).

Article

CAS

PubMed

Google Scholar

Schudel, A., Francis, D. M. & Thomas, S. N. Material design for lymph node drug delivery. Nat. Rev. Mater. 4, 415–428 (2019).

Article

PubMed

PubMed Central

Google Scholar

Hassett, K. J. et al. Impact of lipid nanoparticle size on mRNA vaccine immunogenicity. J. Control. Release 335, 237–246 (2021).

Article

CAS

PubMed

Google Scholar

Li, B. et al. Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA. Nat. Biomed. Eng. 9, 167–184 (2025).

Article

CAS

PubMed

Google Scholar

Hassett, K. J. et al. Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines. Mol. Ther. Nucleic Acids 15, 1–11 (2019).

Article

CAS

PubMed

PubMed Central

Google Scholar

Vadovics, M. et al. Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modifications. Nat. Nanotechnol. 20, 1312–1322 (2025).

Article

ADS

CAS

PubMed

PubMed Central

Google Scholar

Kawaguchi, Y. et al. Modulating immunogenicity and reactogenicity in mRNA-lipid nanoparticle vaccines through lipid component optimization. ACS Nano 19, 27977–28001 (2025).

Article

CAS

PubMed

PubMed Central

Google Scholar

Han, X. et al. Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines. Nat. Nanotechnol. 18, 1105–1114 (2023).

Article

ADS

CAS

PubMed

Google Scholar

Szebeni, J. et al. Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines. Nat. Nanotechnol. 17, 337–346 (2022).

Article

ADS

CAS

PubMed

Google Scholar

Ju, Y. et al. Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine. ACS Nano 16, 11769–11780 (2022).

Article

CAS

PubMed

Google Scholar

Carreno, J. M. et al. mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations. Vaccine 40, 6114–6124 (2022).

Article

CAS

PubMed

PubMed Central

Google Scholar

Guerrini, G. et al. Monitoring anti-PEG antibodies level upon repeated lipid nanoparticle-based COVID-19 vaccine administration. Int. J. Mol. Sci. 23, 8838 (2022).

Article

CAS

PubMed

PubMed Central

Google Scholar

Kozma, G. T. et al. Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG. Vaccine 41, 4561–4570 (2023).

Article

CAS

PubMed

PubMed Central

Google Scholar

Pardi, N. et al. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. J. Exp. Med. 215, 1571–1588 (2018).

Article

CAS

PubMed

PubMed Central

Google Scholar

Corbett, K. S. et al. Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine-boosted nonhuman primates. Science 374, 1343–1353 (2021).

Article

ADS

CAS

PubMed

Google Scholar

Cortese, M. et al. System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans. Nat. Immunol. 26, 116–130 (2025).

Article

CAS

PubMed

PubMed Central

Google Scholar

Buhre, J. S. et al. mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine. Front. Immunol. 13, 1020844 (2022).

Article

CAS

PubMed

Google Scholar

Irrgang, P. et al. Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. Sci. Immunol. 8, eade2798 (2023).

Article

CAS

PubMed

PubMed Central

Google Scholar

Pillai, S. Is it bad, is it good, or is IgG4 just misunderstood? Sci. Immunol. 8, eadg7327 (2023).

Article

CAS

PubMed

Google Scholar

Chung, A. W. et al. Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines. Sci. Transl. Med. 6, 228ra238 (2014).

Article

Google Scholar

Kapellos, T. S. et al. Human monocyte subsets and phenotypes in major chronic inflammatory diseases. Front. Immunol. 10, 2035 (2019).

Article

CAS

PubMed

PubMed Central

Google Scholar

Wong, K. L. et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 118, e16–e31 (2011).

Article

CAS

PubMed

Google Scholar

Cabeza-Cabrerizo, M., Cardoso, A., Minutti, C. M., Pereira da Costa, M. & Reis e Sousa, C. Dendritic cells revisited. Annu. Rev. Immunol. 39, 131–166 (2021).

Article

CAS

PubMed

Google Scholar

Varol, C., Mildner, A. & Jung, S. Macrophages: development and tissue specialization. Annu. Rev. Immunol. 33, 643–675 (2015).

Article

CAS

PubMed

Google Scholar

Vivier, E., Tomasello, E., Baratin, M., Walzer, T. & Ugolini, S. Functions of natural killer cells. Nat. Immunol. 9, 503–510 (2008).

Article

CAS

PubMed

Google Scholar

Plotkin, S. A. Correlates of protection induced by vaccination. Clin. Vaccine Immunol. 17, 1055–1065 (2010).

Article

CAS

PubMed

PubMed Central

Google Scholar

Victora, G. D. & Nussenzweig, M. C. Germinal centers. Annu. Rev. Immunol. 40, 413–442 (2022).

Article

CAS

PubMed

Google Scholar

Nutt, S. L., Hodgkin, P. D., Tarlinton, D. M. & Corcoran, L. M. The generation of antibody-secreting plasma cells. Nat. Rev. Immunol. 15, 160–171 (2015).

Article

CAS

PubMed

Google Scholar

Crotty, S. T. Follicular helper cell biology: a decade of discovery and diseases. Immunity 50, 1132–1148 (2019).

Article

CAS

PubMed

PubMed Central

Google Scholar

Chung, H. K., McDonald, B. & Kaech, S. M. The architectural design of CD8+ T cell responses in acute and chronic infection: parallel structures with divergent fates. J. Exp. Med. 218, e20201730 (2021).

Article

CAS

PubMed

PubMed Central

Google Scholar